|
G |
GJA1 |
gap junction protein alpha 1 |
affects expression |
EXP |
Flutamide affects the expression of GJA1 mRNA |
CTD |
PMID:20961722 |
|
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
|
|
|
G |
PGK1 |
phosphoglycerate kinase 1 |
increases alkylation |
EXP |
methyl iodide results in increased alkylation of PGK1 protein |
CTD |
PMID:6697999 |
|
NCBI chr X:62,187,472...62,210,321
Ensembl chr X:62,187,434...62,210,705
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:38432436 |
|
|
|
G |
AKT2 |
AKT serine/threonine kinase 2 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of AKT2 protein |
CTD |
PMID:38432436 |
|
NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919
|
|
G |
AKT3 |
AKT serine/threonine kinase 3 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of AKT3 protein |
CTD |
PMID:38432436 |
|
NCBI chr10:16,441,465...16,741,745
Ensembl chr10:16,441,447...16,741,337
|
|
G |
ATG5 |
autophagy related 5 |
increases expression |
EXP |
norflurazone results in increased expression of ATG5 protein |
CTD |
PMID:38432436 |
|
NCBI chr 1:72,343,950...72,520,402
Ensembl chr 1:72,270,799...72,520,396
|
|
G |
ATP5F1A |
ATP synthase F1 subunit alpha |
decreases expression |
EXP |
norflurazone results in decreased expression of ATP5F1A mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 1:95,738,789...95,750,835
Ensembl chr 1:95,733,090...95,750,841
|
|
G |
ATP5MC1 |
ATP synthase membrane subunit c locus 1 |
decreases expression |
EXP |
norflurazone results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr12:25,110,540...25,113,481
Ensembl chr12:25,110,528...25,113,478
|
|
G |
ATP5MC2 |
ATP synthase membrane subunit c locus 2 |
decreases expression |
EXP |
norflurazone results in decreased expression of ATP5MC2 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 5:18,871,025...18,879,933
Ensembl chr 5:18,871,026...18,879,609
|
|
G |
ATP5PB |
ATP synthase peripheral stalk-membrane subunit b |
decreases expression |
EXP |
norflurazone results in decreased expression of ATP5PB mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 4:108,896,063...108,907,626
Ensembl chr 4:108,896,057...108,907,805
|
|
G |
BECN1 |
beclin 1 |
increases expression |
EXP |
norflurazone results in increased expression of BECN1 protein |
CTD |
PMID:38432436 |
|
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
|
|
G |
CYP2C49 |
cytochrome P450 2C49 |
multiple interactions |
EXP |
CYP2C49 protein results in increased metabolism of and results in decreased susceptibility to norflurazone |
CTD |
PMID:16315095 |
|
NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
norflurazone results in increased phosphorylation of EIF2A protein |
CTD |
PMID:38432436 |
|
NCBI chr13:90,761,453...90,804,274
Ensembl chr13:90,761,465...90,804,274
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
norflurazone results in increased expression of and results in increased phosphorylation of HSPA5 protein |
CTD |
PMID:38432436 |
|
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
increases expression |
EXP |
norflurazone results in increased expression of ITPR1 protein |
CTD |
PMID:38432436 |
|
NCBI chr13:61,068,131...61,398,918
Ensembl chr13:61,068,126...61,398,912
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:38432436 |
|
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
increases phosphorylation |
EXP |
norflurazone results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:38432436 |
|
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:38432436 |
|
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
|
|
G |
MT-ATP6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
decreases expression |
EXP |
norflurazone results in decreased expression of ATP6 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr MT:9,120...9,800
Ensembl chr MT:9,120...9,800
|
|
G |
NDUFS2 |
NADH:ubiquinone oxidoreductase core subunit S2 |
decreases expression |
EXP |
norflurazone results in decreased expression of NDUFS2 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 4:89,246,958...89,257,090
Ensembl chr 4:89,246,960...89,257,085
|
|
G |
NDUFS3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
decreases expression |
EXP |
norflurazone results in decreased expression of NDUFS3 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 2:15,031,147...15,036,880
Ensembl chr 2:15,031,149...15,036,880
|
|
G |
NDUFV1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
decreases expression |
EXP |
norflurazone results in decreased expression of NDUFV1 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 2:4,958,508...4,964,211
Ensembl chr 2:4,958,522...4,964,216
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
EXP |
norflurazone results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:38432436 |
|
NCBI chr12:36,111,584...36,159,287
Ensembl chr12:36,111,653...36,160,376
|
|
G |
SMAD2 |
SMAD family member 2 |
decreases expression |
EXP |
norflurazone results in decreased expression of SMAD2 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 1:97,415,360...97,511,388
Ensembl chr 1:97,415,716...97,511,357
|
|
G |
SMAD4 |
SMAD family member 4 |
decreases expression |
EXP |
norflurazone results in decreased expression of SMAD4 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
norflurazone results in decreased expression of SPP1 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
|
|
G |
SQSTM1 |
sequestosome 1 |
increases phosphorylation |
EXP |
norflurazone results in increased phosphorylation of SQSTM1 protein |
CTD |
PMID:38432436 |
|
NCBI chr 2:78,752,768...78,763,998
Ensembl chr 2:78,752,771...78,763,938
|
|
G |
UQCRB |
ubiquinol-cytochrome c reductase binding protein |
decreases expression |
EXP |
norflurazone results in decreased expression of UQCRB mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 4:40,403,272...40,409,080
Ensembl chr 4:40,403,109...40,409,057
|
|
G |
UQCRC2 |
ubiquinol-cytochrome c reductase core protein 2 |
decreases expression |
EXP |
norflurazone results in decreased expression of UQCRC2 mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 3:24,197,743...24,228,831
Ensembl chr 3:24,197,747...24,228,832
|
|
G |
UQCRQ |
ubiquinol-cytochrome c reductase complex III subunit VII |
decreases expression |
EXP |
norflurazone results in decreased expression of UQCRQ mRNA |
CTD |
PMID:38432436 |
|
NCBI chr 2:135,186,366...135,188,237
Ensembl chr 2:135,186,501...135,188,293
|
|
G |
VDAC1 |
voltage dependent anion channel 1 |
increases expression |
EXP |
norflurazone results in increased expression of VDAC1 protein |
CTD |
PMID:38432436 |
|
NCBI chr 2:136,302,188...136,334,461
Ensembl chr 2:136,302,191...136,396,301
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
EXP |
perfluorooctanoic acid results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:38145882 |
|
|
|
G |
ALB |
albumin |
affects binding |
EXP |
perfluorooctanoic acid binds to ALB protein |
CTD |
PMID:38518100 |
|
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
|
|